Cysteamine bitartrate delayed-release (Procysbi®)
Procysbi® for the treatment of proven nephropathic cystinosis.
NCPE Assessment Process | Completed |
Rapid review received | 01/12/2015 |
Rapid review completed | 15/12/2015 |
Rapid Review Outcome | Full pharmacoeconomic assessment recommended at the submitted price |
Full pharmacoeconomic assessment commissioned by HSE | 23/12/2015 |
Pre-submission consultation with applicant | 22/05/2017 |
Submission received from applicant | 13/07/2017 |
Preliminary review sent to applicant | 22/08/2017 |
NCPE assessment re-commenced | 29/08/2017 |
Applicant factual accuracy check | 17/10/2017 |
NCPE assessment re-commenced | 15/11/2017 |
NCPE assessment completed | 15/11/2017 |
NCPE assessment outcome | Reimbursement not recommended at the submitted price |
The HSE has approved reimbursement following confidential price negotiations; July 2019